Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
Author:
Open Access
- 1 April 2010
- journal article
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. 2, 89-101
Abstract
Peer reviewed article authored by (Jose A Vazquez). Read article or submit your manuscript for publishing.Keywords
This publication has 96 references indexed in Scilit:
- Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasisExpert Reviews in Molecular Medicine, 2008
- Safety and Efficacy of Posaconazole in the Long-Term Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Patients with HIV InfectionHIV Research & Clinical Practice, 2007
- Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida EsophagitisGastroenterology, 1996
- Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasisOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1996
- Mixed oropharyngeal candidiasis due toCandida albicans and non-albicans Candida strains in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Comparison of Itraconazole and Ketoconazole in HIV-Positive Patients with Oropharyngeal or Esophageal CandidiasisChemotherapy, 1996
- Oral Candida albicans Isolates with Reduced Susceptibility to Fluconazole in Swedish HIV-infected PatientsScandinavian Journal of Infectious Diseases, 1995
- Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIVAIDS, 1991
- Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Treatment of Infections Associated with Human Immunodeficiency VirusNew England Journal of Medicine, 1988